MARCHing onward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
100s of millions being held by investors, not selling in 2017. Easy to understand from my investment point of view.
100s of millions of shares are being held by MYDX investors and are selling into shorter manipulation. MYDX investors bought in March when they realized how huge MYDX is and will continue to accumulate shares and because it's an investment, NO SHARES will be sold 2017.
MYDX investors get to keep 100s of millions of shares and continue accumulating. No investors have to sell 2017, why would they? That's what an investment is, hold for at least a year. Investors will make a nice return 2018 and beyond and continue accumulating.
No MYDX investors are selling in 2017.
The pps hasn't dropped more than 10% in a single day of trade in a very long time. That says a lot right there.
"The Multi-Billion Dollar North American Cannabis Market; Publicly Traded Company Directory Preview Released"
"You will not find another multi-billion-dollar market growing at 25 percent anywhere in the world that is not already filled with multi-national companies and institutional investors" - Arcview Market Research"
(Link to follow)
MYDX, the best kept secret on this list of companies. Investors will be buying indefinitely into MYDX when they hear about MYDX's current product on the market and all of MYDX's products to be on the market. I believe investors will buyin much less before all products hit the market. It will be a scramble I believe for investors to get in under .025 with enough exposure.
http://www.investorideas.com/news/2017/marijuana/02061Directory.asp
http://www.todayinhealthcare.com
Quote:
"One area where lab testing is absolutely set to expand significantly is California—the largest single producer and consumer of cannabis in America—where none of the marijuana is subject to state quality-control standards and may be sold as-is until Jan. 1, 2018."
MYDX is proving CannaDX is reliable for the everyday cannabis consumer to "trust & verify" to determine before inhaling if that is the strain that the consumer intended to put in their body. They will do this before 2018 by the time its required for dispensaries to follow quality standards.
Medicinal cannabis sector will be revolutionized with the release of "Powered By MYDX" medicinal cannabis vape pens which will cater to the specific needs of doctors looking to remedy the specific needs of the patients with the direct ability to measure effectiveness of doses through the vape pens ability by design to communicate via bluetooth to smart devices.
https://finance.yahoo.com/news/mydx-enters-80-000-mydx360-130000842.html?.tsrc=applewf
The whole thing is great, but this is my favorite part:
Quote:
"The MyDx360 platform makes it incredibly easy for market players to create new high quality tailored formulations that can support their customer's needs. It also speaks to our ability as a company to execute on our vision of creating a brand centric ecosystem powered by community driven data."
http://www.wandtv.com/story/35675235/mydx-launches-canadian-national-marketing-campaign-to-promote-transparency-and-prevent-abuse-with-its-cannadx-cannabis-handheld-chemical-analyzer
Good news travels fast and free.
Quote:
"Aphria (APH), one of Canada’s largest licensed Marijuana grower’s, called on the government to determine “clear and enforceable rules to ensure that customers are protected and have access to clean and safe products.” Other licensed producers are also starting to take measures to self-regulate and go above and beyond the regulatory requirements until further defined. The MyDx handheld analyzer for Cannabis (also known as CannaDx) goes hand in hand with those efforts to identify important chemicals profiles and the effects on consumers. This is a very unique opportunity for Canadian producers and MyDx to work together to track feedback from consumers that is tied directly to a chemical profile with over 48,000 datasets collected to date."
Big Pharma let MYDX take the risk? Is it because Big Pharma knows it will be years before cannabis becomes legal at federal level even though it is becoming legal by the states? Is it because Big Pharma knows they can just buy into MYDX's first to market smart medicinal cannabis vape pens due to market availability by end of this year? Big Pharma will have to go through MYDX?
Is it because Big Pharma knows they can just buy their way in? Why no big pharma producing a smart vape pen in the medicinal cannabis market that communicates data by Bluetooth? Don't they have significant resources and ability or will they just buy their way in because they know MYDX is already doing it and plans on bringing the product to market by end of year? What effect will that have on current shareholders?
FACT: MYDX is currently marketing the MYDX 360 platform specifically catering to MYDX branded medicinal cannabis vape pens in Canada, which is actually two products MYDX has begun to sell so there's where the Canada market is as of now. It's not hard for me to understand why MYDX chose a strong marketing campaign in Canada as opposed to US. Canada will be ahead of US and it's looking like Mexico will also lead US in full legalization policy. I believe US is a much better market to campaign in before Mexico however even if US isn't fully legal by then. Many other countries are fully legalizing and will be very anxious to get on board the MYDX wagon since it won't be long before MYDX is proven to be THE CANNABIS INDUSTRY SUCCESS STORY OF ALL TIME!!
In case there are ACTUAL people doubting MYDX's potential foothold in Canada before next year's Canadian legalization policy:
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
Here is another reason NOT to doubt MYDX's potential foothold in Canada before next year:
https://finance.yahoo.com/news/mydx-launches-canadian-national-marketing-191000550.html?.tsrc=applewf
MYDX "BACKED BY FACT"
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Is HIPPA compliance important (reference link to follow)?
"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."
http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider
MYDX setting itself apart in medicinal cannabis market (reference link to follow):
"Since the inception of MyDx's handheld testing device, MyDx has been accumulating data tying the net physiological effects of cannabis to its chemical profile and is the only company in the industry that actively collects this sort of data with such specificity. And this has created a whole new business segment that is tied to the pharmaceutical industry."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
https://www.google.com/amp/s/amp.theguardian.com/us-news/2017/apr/03/big-pharma-marijuana-competition-insys-arizona
Why would Big Pharma want to stop something they don't care to get into?
Big Pharma let MYDX take the risk? Is it because Big Pharma knows it will be years before cannabis becomes legal at federal level even though it is becoming legal by the states? Is it because Big Pharma knows they can just buy into MYDX's first to market smart medicinal cannabis vape pens due to market availability by end of this year? Big Pharma will have to go through MYDX? What effect will this have on current shareholders?
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
The following link is evidence that US is motivated to move forward with regulating cannabis to eliminate harmful black market weed. This will only help the MYDX cause and what the company is working hard to accomplish transparency within a relatively hidden market:
www.massroots.com/news/fentanyl-laced-cannabis?utm_content=bufferdcab2&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer
MYDX "BACKED BY FACT" http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:
"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"
How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Investors are looking at no less than a 10 Billion dollar MYDX valuation easy for any corporation looking to buyout MYDX. MYDX is the only product to offer a social solution of transparency to current compromised Black market weed. What effect would this have on current MYDX investors?
You do realize that different alcohol brands and products have different alcohol contents that are required by law to have written on labels? You do realize that the more alcohol by volume beverage will have more of an effect on the body than a lesser alcohol by volume beverage? I thought this was common knowledge. Anyway, MYDX is licensing specially designed cannabis concoctions for companies to brand and label for their own distribution to the consumer, namely, doctors to patients because patients trust doctors and doctors trust a product that says "Powered by MYDX"
It's more likely existing industry is being shook up by MYDX's revolutionary medicinal cannabis vape pen's ability to communicate to smart devices about their smoking uses and effectiveness. This has many medicinal applications that will eventually make current vape pens look like child's play and not something responsible adults should be using for cannabis products. MYDX vape pens for responsible adults as drinking responsibly means being 21 and that's legal jargon.
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results!!
MYDX Long And Strong
NEW MYDX SLOGAN: "Before you buy or try, "trust & verify"
For all I know, that mystery weed I had, which is why I'm invested in the success of this company, was laced with that harmful chemical. There is no way I feel safe smoking someone else's weed without going through the MYDX "trust and verify" process. It would be irresponsible for me, as the consumer to just assume what I'm smoking is safe. HELL NO!!
I'm living proof of how this device can help consumers of cannabis determine what strain they never want to put in their bodies ever again. All consumers have to do is test a sample before they smoke it and compare it to their previous results and determine based on the database whether or not it's a strain that has worked for them.
Pps wouldn't be where it is if it weren't being shorted. Who said in March the stock would be shorted?
No investors are selling 2017.
Define fast. Less than 10% a day because it's being shorted is not fast, that's one day at a time, each day being 24 hrs. And each trading day being 6 hours and 30 minutes.
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
http://www.wandtv.com/story/35727986/technology-and-markets-news-provider-gekbuzz-says-the-marijuana-vape-industry-expected-to-reach-billions-by-2021
Quote:
"Widely used by marijuana enthusiasts, vaporizers have historically been low-cost, low-tech products. But many in the industry are now adopting business models that are more in line with tech giants like Apple, Samsung, and Sony as a means to grow sales.
One such company, MYDX, which is leading in Vaporizer Technology on top of their patented technology expects revenues to increase 35 percent each year through 2021. MYDX INC is soaring due to state of the art cannabis-vaporizing pen development."
35% increase each year through 2021, sounds reasonable since it is LEADING in vaporizer technology!
http://www.todayinhealthcare.com
Quote:
"One area where lab testing is absolutely set to expand significantly is California—the largest single producer and consumer of cannabis in America—where none of the marijuana is subject to state quality-control standards and may be sold as-is until Jan. 1, 2018."
MYDX is proving CannaDX is reliable for the everyday cannabis consumer to "trust & verify" to determine before inhaling if that is the strain that the consumer intended to put in their body. They will do this before 2018 by the time its required for dispensaries to follow quality standards.
"The Multi-Billion Dollar North American Cannabis Market; Publicly Traded Company Directory Preview Released"
"You will not find another multi-billion-dollar market growing at 25 percent anywhere in the world that is not already filled with multi-national companies and institutional investors" - Arcview Market Research"
(Link to follow)
MYDX, the best kept secret on this list of companies. Investors will be buying indefinitely into MYDX when they hear about MYDX's current product on the market and all of MYDX's products to be on the market. I believe investors will buyin much less before all products hit the market. It will be a scramble I believe for investors to get in under .025 with enough exposure.
http://www.investorideas.com/news/2017/marijuana/02061Directory.asp
FACT: MYDX is currently marketing the MYDX 360 platform specifically catering to MYDX branded medicinal cannabis vape pens in Canada, which is actually two products MYDX has begun to sell so there's where the Canada market is as of now. It's not hard for me to understand why MYDX chose a strong marketing campaign in Canada as opposed to US. Canada will be ahead of US and it's looking like Mexico will also lead US in full legalization policy. I believe US is a much better market to campaign in before Mexico however even if US isn't fully legal by then. Many other countries are fully legalizing and will be very anxious to get on board the MYDX wagon since it won't be long before MYDX is proven to be THE CANNABIS INDUSTRY SUCCESS STORY OF ALL TIME!!
In case there are ACTUAL people doubting MYDX's potential foothold in Canada before next year's Canadian legalization policy:
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
Here is another reason NOT to doubt MYDX's potential foothold in Canada before next year:
https://finance.yahoo.com/news/mydx-launches-canadian-national-marketing-191000550.html?.tsrc=applewf
MYDX "BACKED BY FACT"
MYDX "BACKED BY FACT" http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:
"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"
How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?
I absolutely believe you are on to something there, the only thing that makes it easy to doubt that that is absolutely what is going on is that even at .022, it is still buying in at a great price for an investment and there was actually ample time and opportunities for any of those guys to buy in on the way up below .01. I believe this is the result ultimately due to quick profit taking. This is hard to deny due to the fact it only took 10-15 trading days to get from .002-.022 AND it happened all of a sudden which is why it's so difficult for MYDX investors to believe any negative outcomes from this investment.
I agree, the best measurement to determine MYDX's improvements on its finanacial status is the financials themselves, and about the alexa thing, are websites ranked by number of total visitors to each website? If the ranking drops for cdx website, does that necessarily mean there is a direct relationship to number of visitors? Is it possible cdx website visitors are actually increasing in rate time over time but are decreasing in ranking?
In case there are ACTUAL people doubting MYDX's potential foothold in Canada before next year's Canadian legalization policy:
Regarding Canada Cannabis Pesticide Regulations: http://www.cannabisfn.com/health-canada-mandates-cannabis-testing-pesticides/
You'll notice, this reference comes from an article published a month ago on the website of the company that handles MYDX's media marketing. This communicates to me that the more MYDX is involved with Canadian cannabis pesticide regulations, the more it will be involved in the beginning of US Cannabis pesticide regulations. If this is why MYDX chose Canada in marketing campaign ahead of US, investors are in for a HUGE payday in the years to come if not months. Genius I tell ya, investors are in good hands with MYDX.
Quote:
"Should United States growers expect similar measures?
As mentioned, there’s a lot that remains to be seen regarding the legality around cannabis in the U.S. given the mixed access across states.
But chances are, should cannabis become legal country-wide, officials will be looking at the models of standardization and quality control in other countries, like Canada, to inform future policies and practices.
Therefore, while no one can say for certain what will and will not be authorized with respect to medical marijuana testing, it’s safe to assume that there will be parallels between how Canada is managing medical marijuana and how the U.S. will plan to."
Here is another reason NOT to doubt MYDX's potential foothold in Canada before next year:
https://finance.yahoo.com/news/mydx-launches-canadian-national-marketing-191000550.html?.tsrc=applewf
MYDX "BACKED BY FACT"
FACT: MYDX is currently marketing the MYDX 360 platform specifically catering to MYDX branded medicinal cannabis vape pens in Canada, which is actually two products MYDX has begun to sell so there's where the Canada market is as of now. It's not hard for me to understand why MYDX chose a strong marketing campaign in Canada as opposed to US. Canada will be ahead of US and it's looking like Mexico will also lead US in full legalization policy. I believe US is a much better market to campaign in before Mexico however even if US isn't fully legal by then. Many other countries are fully legalizing and will be very anxious to get on board the MYDX wagon since it won't be long before MYDX is proven to be THE CANNABIS INDUSTRY SUCCESS STORY OF ALL TIME!!
MYDX "BACKED BY FACT": MYDX's MOST RECENT MOVEMENT THIS YEAR was a move taking sp UP 10 times from the .002's to the .022's. Sp since then has moved down to the .006's, which is just below the halfway point from its peak. MYDX's 200dma has remained, since the 10x rise, above the 50dma which indicates BULLISH trend. Since the major move upward with significant volume, there has not been any major shift downward in a day's time with significant volume. It has been a slow, steady, and low volume downward trend over a long period of time. The BIG QUESTION is: Will the next major move in high volume result in the "golden cross" which is when the 50dma rises above the 200dma or will the next major move result in the "death cross" which is when the 200mda falls below 50dma?
MYDX "BACKED BY FACT": MYDX is a high risk long-term volatile investment. The sp frequently has sp +/- changes over 5%.
MYDX "BACKED BY FACT": MYDX's financials currently are NOT a positive attribute to the MYDX investor. What is a positive attribute to the MYDX investor is the company marketing for the first time a MAJOR campaign in an emerging market: CANADA. The more people that know about MYDX's REAL product (CannaDX) that is REALLY producing revenue-generating data by its MYDX 360 platform, which is already being applied to the MYDX upcoming medicinal vape pen licensing product, the more new consumers and investors will realize that MYDX is here to STAY!!!
MYDX Long and Strong
Attached below is a link explaining what a "golden cross" is compared to a "death cross."
http://thereformedbroker.com/2012/03/22/golden-crosses-the-bible/
Numbers WILL SHOW improvements!
Compare numbers, numbers are facts and they will show improvements, fact not speculation.
The facts show how MYDX has improved and will continue to improve given the short period this company has been in existence and is shaping an industry and creating new segments. Not too bad for a little company eh?
The facts are the numbers, judgments are speculation, not facts.
FACTS are in FAVOR of MYDX!
I posted a link to that and is quite reflective in reality to have a negative effect on sp of credible companies.
it is common knowledge when it was dated, I even mentioned that once before, no one is duped.
Questions and concerns of that nature can be taken up with the company.